Streetbeat News

Earnings

AFYA

Afya reported Q3 earnings of $0.21 per share, down from $0.24 YoY. Quarterly sales were $148.23K, significantly missing the $140.74M estimate and representing a 99.87% decrease from $110.83M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 9:24 pm

AP

Ampco-Pittsburgh (NYSE:AP) reported Q3 2023 earnings of $0.04 per share, consistent with the same period last year. Sales rose 2.58% to $102.22M from $99.65M YoY.

Portfolio Pulse from saritha@benzinga.com

November 13, 2023 | 9:23 pm

RVYL

RYVYL projects its Q4 2023 revenue to be between $19M and $21M, surpassing the estimated $17M.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 9:23 pm

DCTH

Delcath Systems (NASDAQ:DCTH) reported a Q3 EPS loss of $(1.14), significantly missing the $(0.52) estimate, and sales of $434.00K, which also fell short of the $680.00K estimate. Compared to the same period last year, EPS decreased by 23.91% and sales dropped by 52.10%.

Portfolio Pulse from bharat@benzinga.com

November 13, 2023 | 9:23 pm

RVYL

RYVYL reported a significant improvement in its Q3 2023 earnings per share (EPS), posting $(0.60) compared to $(3.37) in the same quarter of the previous year. The company's revenue also surpassed expectations, coming in at $17.5 million against an estimate of $15.7 million.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 9:22 pm

GRND

Grindr has updated its FY23 outlook, projecting revenue growth to exceed 31%. The company also anticipates a year-over-year growth of over 25% for Q4.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 9:21 pm

GRND

Grindr reported a Q3 EPS of $0.00, an improvement from $(0.03) year-over-year (YoY). Sales increased to $70.26M from $50.40M YoY, indicating significant revenue growth.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 9:20 pm

RBOT

Vicarious Surgical (NYSE:RBOT) reported a Q3 adjusted EPS loss of $(0.12), surpassing analyst expectations of $(0.15) by 20%. The result marks a 33.33% improvement from the $(0.18) per share loss reported in the same quarter of the previous year.

Portfolio Pulse from bharat@benzinga.com

November 13, 2023 | 9:20 pm

ELUT

Elutia (NASDAQ:ELUT) reported Q3 earnings with an EPS of $-0.5, beating estimates by 7.41% but with a revenue decrease of $6.26 million YoY. Despite missing EPS last quarter, the stock increased by 6.72% the following day. Historical earnings show variability in performance.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 9:20 pm

CLSD

Clearside Biomedical (NASDAQ:CLSD) reported Q3 earnings with an EPS of $-0.15, which was in line with estimates. Revenue increased by $593 thousand compared to the same period last year. The company's stock price dropped 6.6% the day after missing EPS estimates last quarter.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 9:20 pm